- Research works
- 68 ◆ 1% vs 2018-21
- Citations
- 2.6k 38.5 per fractional work
- Top-10% rate
- 8.3% all institutions 10.0%
- Open access
- 42% world 40%
- International
- 31% world 18%
Not ranked overall: Omeros Corporation (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Omeros Corporation (United States) work in?
In all years, 52% of research at Omeros Corporation (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (20%). It does 2.9× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 21 fields, with their numbers
- Life Sciences3551.8%
- Health Sciences2334.4%
- Medicine2333.8%
- Nursing00.5%
- Health Professions00.2%
- Physical Sciences710.3%
- Engineering45.2%
- Physics and Astronomy11.2%
- Computer Science11.1%
- Materials Science11.0%
- Chemistry10.9%
- Environmental Science00.7%
- Energy00.2%
- Social Sciences23.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 22.1×. Every wedge is a field page.
All 8 fields, with their numbers
- Immunology and Microbiology22.11×2 works
- Medicine3.14×6 works
- Biochemistry, Genetics and Molecular Biology1.97×1 works
- Business, Management and Accounting1.10×0 works
- Neuroscience1.04×0 works
- Health Professions0.45×0 works
- Decision Sciences0.22×0 works
- Arts and Humanities0.07×0 works
Who are the top researchers at Omeros Corporation (United States)?
Ranked on the quality score, Steve Whitaker, George Gaitanaris and Thomas Dudler lead among researchers whose main affiliation is Omeros Corporation (United States).
- 1
Steve Whitaker
United States · #574,094 worldwide 1.7k citations · 22 works
- 2
George Gaitanaris
United States · #723,795 worldwide 3k citations · 38 works
- 3
Thomas Dudler
United States · #736,275 worldwide 1.8k citations · 32 works
- 4
David A. Basiji
United States · #938,949 worldwide 1.4k citations · 20 works
- 5
Thaddeus C. George
United States · #971,002 worldwide 3k citations · 34 works
- 6
Brian E. Hall
United States · #1,121,891 worldwide 3.3k citations · 68 works
- 7
Alexander Gragerov
United States · #1,177,230 worldwide 3k citations · 23 works
- 8
Thaddeus C. George
United States · #1,207,292 worldwide 1.3k citations · 36 works
- 9
Sherree L. Friend
United States · #1,329,118 worldwide 1.2k citations · 30 works
- 10
Gregory A. Demopulos
United States · #1,703,812 worldwide 1.1k citations · 40 works
Which keywords describe research at Omeros Corporation (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Innate Immunity, Inflammation, Regulation, Immunity, Cancer Immunotherapy, Complement, Immune and Genetics.
- Thrombosis
- Autoimmunity
- Pattern Recognition Receptors
- NK Cell Recognition
- CD47
- Vaccine Adjuvants
- Toll-like Receptors
- Immune Regulation
- Fc Receptors
- Therapeutic Targets
- Reactive Oxygen Species
- Dendritic Cells
- Bioimage Analysis
- Image Processing
- Gene Expression
- Immune
- Machine Learning
- Cancer Immunotherapy
- Cancer
- Innate Immunity
- Inflammation
- Regulation
- Immunity
- Genetics
- Complement
- Deep Learning
- Glycosylation
- Monoclonal Antibodies
- High-Content Screening
- Pharmacology
- Therapeutic Antibodies
- Antibody Engineering
- Antigen Presentation
- Stress
- Tumor Antigen
- Macrophages
- apoptotic cells
- Natural Killer Cells
- Tumor Targeting
- Glaucoma
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation8▲ 4.8×31 topics
- Innate Immunity6▲ 28×6 topics
- Regulation4▲ 9.9×4 topics
- Cancer4▲ 4.1×13 topics
- Immunity4▲ 17×6 topics
- Cancer Immunotherapy4▲ 40×3 topics
- Genetics4▲ 6.7×3 topics
- Machine Learning4▲ 2.4×5 topics
- Complement3▲ 235×1 topic
- Immune3▲ 235×1 topic
- Deep Learning3▲ 2.3×4 topics
- Gene Expression3▲ 6.3×5 topics
- Glycosylation3▲ 17×2 topics
- Image Processing3▲ 12×2 topics
- Monoclonal Antibodies2▲ 26×3 topics
- Bioimage Analysis2▲ 136×1 topic
- High-Content Screening2▲ 136×1 topic
- Dendritic Cells2▲ 29×2 topics
- Pharmacology2▲ 10×3 topics
- Reactive Oxygen Species2▲ 6.7×7 topics
- Therapeutic Antibodies2▲ 27×2 topics
- Therapeutic Targets2▲ 15×4 topics
- Antibody Engineering2▲ 32×1 topic
- Fc Receptors2▲ 32×1 topic
- Antigen Presentation2▲ 30×2 topics
- Immune Regulation2▲ 23×3 topics
- Stress2▲ 7.3×3 topics
- Toll-like Receptors2▲ 17×3 topics
- Tumor Antigen2▲ 37×1 topic
- Vaccine Adjuvants2▲ 37×1 topic
- Macrophages2▲ 17×2 topics
- CD472▲ 168×1 topic
- apoptotic cells2▲ 168×1 topic
- NK Cell Recognition2▲ 24×1 topic
- Natural Killer Cells2▲ 24×1 topic
- Pattern Recognition Receptors2▲ 16×2 topics
- Tumor Targeting2▲ 18×3 topics
- Autoimmunity2▲ 11×4 topics
- Glaucoma2▲ 14×2 topics
- Thrombosis2▲ 10×4 topics
Which research topics does Omeros Corporation (United States) publish most on?
By volume in 2022-now: Complement system in diseases, Monoclonal and Polyclonal Antibodies Research, Renal Diseases and Glomerulopathies and Renal Transplantation Outcomes and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Complement system in diseases Immunology 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 Renal Diseases and Glomerulopathies Nephrology 1 works
- 4 Renal Transplantation Outcomes and Treatments Transplantation 0 works
- 5 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 6 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
- 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 8 Blood groups and transfusion Hematology 0 works
- 9 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
- 10 COVID-19 Clinical Research Studies Infectious Diseases 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Omeros Corporation (United States)'s research output changed?
Output in 2022-2025 was 1% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Omeros Corporation (United States) as a percentage of every work published that year, 0.000018% in 2024.
Fractional works of Omeros Corporation (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Seattle
- University of Washington
- Seattle University
- Fred Hutch Cancer Center
- Seattle Children's Hospital
- Amazon (United States)
- Allen Institute
- Virginia Mason Medical Center
- Cancer Research And Biostatistics
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Omeros Corporation (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.